C C Chiueh1, H Miyake, M T Peng. Show Affiliations » 1. National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892.
Abstract
Entities: Chemical Disease
Mesh: See more » 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacokinetics1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine/pharmacologyAnimalsBrain/drug effectsBrain/physiopathologyCalcium/physiologyCalcium Channels/drug effectsCalcium Channels/physiologyCell Death/drug effectsCell Death/physiologyCorpus Striatum/drug effectsCorpus Striatum/physiopathologyDopamine/metabolismFree RadicalsHydroxides/metabolismHydroxyl RadicalIron/physiologyMonoamine Oxidase/physiologyNerve Degeneration/drug effectsNerve Degeneration/physiologyNeural Pathways/drug effectsNeural Pathways/physiopathologyOxidation-ReductionParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/physiopathologyPotassium/physiologyPotassium Channels/drug effectsPotassium Channels/physiologyRatsSubstantia Nigra/drug effectsSubstantia Nigra/physiopathology
Substances: See more » Calcium ChannelsFree RadicalsHydroxidesPotassium ChannelsHydroxyl Radical1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineIronMonoamine OxidasePotassiumCalciumDopamine
Year: 1993 PMID: 8380519
Source DB: PubMed Journal: Adv Neurol ISSN: 0091-3952